Identification of ryuvidine as a KDM5A inhibitor-Reference-Cited by-同舟云学术

Identification of ryuvidine as a KDM5A inhibitor

Published:2019-07-09 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Mitsui Eishin^ORCID,Yoshida Shogo,Shinoda Yui,Matsumori Yasumasa,Tsujii Hiroshi,Tsuchida Mie,Wada Shuichi,Hasegawa Makoto,Ito Akihiro,Mino Koshiki,Onuki Tetsuo,Yoshida Minoru^ORCID,Sasaki Ryuzo,Mizukami Tamio

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-46346-x.pdf

Reference61 articles.

1. Berger, S. L. The complex language of chromatin regulation during transcription. Nature 447, 407–412 (2007).

2. Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45 (2000).

3. Zhang, Y. & Reinberg, D. Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes Dev. 15, 2343–2360 (2001).

4. Marmorstein, R. & Trievel, R. C. Histone modifying enzymes: structures, mechanisms, and specificities. Biochim. Biophys. Acta. 1789, 58–68 (2009).

5. Allis, C. D. et al. New nomenclature for chromatin-modifying enzymes. Cell 131, 633–636 (2007).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivity;iScience;2024-07

2. Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and in - vitro evaluation to identify anticancer lead as lysine-specific demethylase 5a inhibitor;Journal of Biomolecular Structure and Dynamics;2024-02-22

3. Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells;MedComm;2023-08-24

4. Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer;Cancer Cell;2023-08

5. Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review;Frontiers in Oncology;2023-07-07